En los últimos 20 años, solo se han aprobado dos nuevos medicamentos que se desarrollaron específicamente para tratar a niños con cáncer. Ahora hay tres. El 10 de marzo de 2015, la FDA aprobó este nuevo medicamento para tratar el neuroblastoma de alto riesgo y lo puso a disposición no solo a través de un ensayo clínico, sino también para todos los niños con este agresivo cáncer infantil. Lea más sobre este increíble avance:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm437460.htm
𝗞𝗲𝗮𝘁𝗼𝗻’𝘀 𝗔𝗻𝗻𝘂𝗮𝗹 𝗛𝗼𝗹𝗹𝘆 𝗝𝗼𝗹𝗹𝘆 𝗖𝗲𝗹𝗲𝗯𝗿𝗮𝘁𝗶𝗼𝗻 𝘄𝗮𝘀 𝗮 𝘁𝗿𝘂𝗹𝘆 𝗺𝗮𝗴𝗶𝗰𝗮𝗹 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲, 𝗯𝗿𝗶𝗻𝗴𝗶𝗻𝗴 𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿 𝗰𝗵𝗶𝗹𝗱 𝗰𝗮𝗻𝗰𝗲𝗿 𝘄𝗮𝗿𝗿𝗶𝗼𝗿𝘀, 𝘁𝗵𝗲𝗶𝗿 𝘀𝗶𝗯𝗹𝗶𝗻𝗴𝘀, 𝗳𝗮𝗺𝗶𝗹𝗶𝗲𝘀, 𝗮𝗻𝗱 𝗰𝗮𝗿𝗲𝗴𝗶𝘃𝗲𝗿𝘀. This special evening offered a heartwarming opportunity to connect with others navigating the childhood cancer journey, while allowing children to simply be kids and enjoy the fun of the holiday season.
Our gratitude is overflowing for everyone who joined us to Strike Out Kids’ Cancers!
Donations made through this event will provide financial, emotional, and educational support to children with cancer and their families as we strive for no child or family to navigate this journey alone. Together, we will continue to Strike Out Kids’ Cancers!
This September, we unite for one purpose: to bring hope, strength, and healing to children battling cancer and their families. Every 3 minutes, a family’s life is turned upside down when they hear the four devastating words, “Your child has cancer.” At Keaton’s Child Cancer Alliance, we believe that every child deserves a fighting chance – and you can help make that a reality.
Child Cancer Alliance de Keaton es una organización sin fines de lucro 501c3, identificación fiscal 68-0406980 y socio certificado de United Way #11669
ES 
EN 
RU